Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1-Reference-Cited by-同舟云学术

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1

Published:2017-09-08 Issue:3 Volume:59 Page:502-508
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Yanik Gregory A.,Parisi Marguerite T.,Naranjo Arlene,Nadel Helen,Gelfand Michael J.,Park Julie R.,Ladenstein Ruth L.,Poetschger Ulrike,Boubaker Ariane,Valteau-Couanet Dominique,Lambert Bieke,Castellani Maria-Rita,Bar-Sever Zvi,Oudoux Aurore,Kaminska Anna,Kreissman Susan G.,Shulkin Barry L.,Matthay Katherine K.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference29 articles.

1. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

2. Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

3. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (SIOPEN/HR-NBL1): an international, randomised, multi-arm, open-label, phase 3 trial;Ladenstein;Lancet Oncol.,2017

4. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

5. Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial;Journal of Clinical Oncology;2024-01-08

2. Nuclear medicine techniques in paediatric body oncology: Present and future;EJC Paediatric Oncology;2023-12

3. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-14

4. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10

5. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma;Seminars in Nuclear Medicine;2023-07